Quantum BioPharma Ltd (NASDAQ:QNTM)’s traded shares stood at 0.45 million during the last session, with the company’s beta value hitting 0.56. At the close of trading, the stock’s price was $19.69, to imply an increase of 3.63% or $0.69 in intraday trading. The QNTM share’s 52-week high remains $23.81, putting it -20.92% down since that peak but still an impressive 86.29% since price per share fell to its 52-week low of $2.70.
Quantum BioPharma Ltd (NASDAQ:QNTM) trade information
After registering a 3.63% upside in the last session, Quantum BioPharma Ltd (QNTM) has traded red over the past five days. The 5-day price performance for the stock is 27.44%, and 139.54% over 30 days. With these gigs, the year-to-date price performance is 435.05%.
QNTM Dividends
Quantum BioPharma Ltd has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Going by data provided on Apr 30, 2025 , AdvisorShares Trust-AdvisorShares Psychedelics ETF holds roughly 66.99 shares. This is just over 2.30% of the total shares, with a market valuation of $1.32 million
